D
Diana Abdulganieva
Researcher at Kazan State Medical University
Publications - 76
Citations - 152
Diana Abdulganieva is an academic researcher from Kazan State Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 20 publications receiving 83 citations.
Papers
More filters
Journal ArticleDOI
Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools
Piet L. C. M. van Riel,Rieke Alten,Bernard Combe,Diana Abdulganieva,Paola Bousquet,Molly Courtenay,Cinzia Curiale,Antonio Gómez-Centeno,Glenn Haugeberg,Burkhard F. Leeb,Kari Puolakka,Angelo Ravelli,Bernhard Rintelen,Piercarlo Sarzi-Puttini +13 more
TL;DR: Several remote monitoring tools that are being developed and used in inflammatory arthritis, offering the potential to improve disease management and reduce pressure on specialists are described, including one that is acceptable to older patients.
Journal ArticleDOI
Coronavirus disease 2019 (COVID-19) and immune-mediated rheumatic diseases. Recommendations of the association of rheumatologists of Russia
E. L. Nasonov,A. M. Lila,Vadim I. Mazurov,B. S. Belov,A. E. Karateev,Tatiana Dubinina,O. A. Nikitinskaya,A. A. Baranov,Diana Abdulganieva,S. V. Moiseev,A. I. Zagrebneva +10 more
TL;DR: The new version of the recommendations of the Association of Rheumatologists of Russia formulates the main provisions concerning the tactics of managing patients with Immune-mediated Rheumatic Diseases during the ongoing COVID-19 pandemic.
Journal ArticleDOI
Serum Cytokine Levels and Their Relation to Clinical Features in Patients with Autoimmune Liver Diseases.
TL;DR: In the language of absolute numbers, the increase of IL-8 serum level by 1 pg/mL had increased the chance for a patient to find himself in a group of AILD by 48.36 times, and high IL- 8 serum levels were strongly related to clinical parameters.
Journal ArticleDOI
The use of Tofacitinib in the treatment of inflammatory bowel disease.
TL;DR: The review examines the molecular aspects of theJAK-STAT signaling pathway, justifying the use of the JAK-kinase inhibitor (tofacitinib) in the treatment of inflammatory bowel disease.
Journal ArticleDOI
Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases
O. M. Drapkina,A I Fedin,O. Dorofeeva,V E Medvedev,E.N. Kareva Kareva,Olga Dzhioeva,S. G. Kuklin,Е. Y. Solovieva,Diana Abdulganieva,Z. F. Kim,M. S. Grigorovich,I I Shaposhnik,Natalia Koryagina,Sergey B. Seredenin +13 more
TL;DR: The conducted studies show that the use of fabomotizole in patients with CVD and concomitant anxiety disorders reduces the anxiety manifestations and a pronounced improvement of somatic status is recorded, which is important for improving the course and prognosis of CVDs.